Background: Carotid artery intima-media thickness (CAIMT) measured by B-mode ultrasonography is widely used as a surrogate marker atherosclerosis. Hyperuricemia is also a well recognized risk factor for cardiovascular diseases. This study was done to find out the role of hyperuricemia on CAIMT and albuminuria, diabetes and hypertension in chronic renal failure (CRF) patients.
Introduction
Increased thickening of carotid artery intima media thickness (CAIMT) is a mirror of generalized atherosclerosis [1] . CAIMT measured noninvasively by ultrasonography is widely used as a surrogate marker of atherosclerosis [2] . Hyperuricemia (HUA) is an independent risk factor for the progression of renal dysfunction [3, 4] and cardiovascular events [3] [4] [5] , and 18.4% of female and 25.8% of male patients with hyperuricemia is suffering from chronic renal failure (CRF) [6] . The National Health Examination Survey III-USA demonstrated that serum uric acid (SUA) level > 5.7 mg/dL is an independent risk factor for Coronary artery disease (CAD) and > 7 mg/dL is an independent risk factor for stroke [7] . A higher SUA level is an atherogenic factor [2] but some study did not include the effect of hyperuricemia on CAIMT [8] . Several studies have shown the association between hyperuricemia and microalbuminuria [9] but some study showed there was lack of relationship between SUA and proteinuria [10] .
This study was done to find out the role of hyperuricemia on CAIMT and albuminuria in CRF patients. Savoiu 
± 45.23 mg and 17.47 ± 0.52 mL/min/1.73 m 2 respectively, 80 (60.6%) were suffering from hypertension (Table 1, 2) .
Healthy controls
Out of 62 healthy controls, 39 (59.1%) male and remaining were female. Mean age of the healthy controls was 46.74 ± 1.19 years. All healthy controls were non smokers, nondyslipidemic, non-hyperuricemic and non-diabetic non-hypertensive, 24 hours total urine albumin excretion was not measurable (Table 1) .
After taking consent, all subjects underwent a careful interview, a clinical examination with an evaluation of patient history based on hospital and outpatients records and laboratory investigations.
Both CRF patients and healthy controls had normal body mass index, body weight and waist circumference.
Biochemical measurements
Venous blood was taken in the morning after an overnight fast for at least 12 hours for biochemical analysis. All biochemical tests were performed at department of biochemistry, Burdwan Medical College.
Uric acid measurement
Hyperuricemia was diagnosed when serum uric acid level was > 7 mg/dL in men and > 6.5 mg/dL in women [11] . Uric acid was measured on a standard auto analyzer.
GFR measurement
CRF was identified when glomerular filtration rate (GFR) was < 60 mL/min/1.73 m 2 for consecutive 3 months or more [10] . Glomerular filtration rate (GFR) was estimated with The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula which includes serum creatinine, age, gender and race as variables, with different versions depending on ethnicity, gender and creatinine value [12] .
Twenty four (24) hours urine total albumin excretion measurement
Twenty four (24) hours urine total albumin excretion is the "gold stander "for measurement of albuminuria [13] and was measured by Esbach's albuninometer. Microalbuminuria is defined when 24 hours total urine albumin excretion is 30 -300 mg and when it is > 300 mg, it is called proteinuria or
CRF Patients
Healthy controls macroalbuminuria [14] .
Plasma glucose measurement
Plasma glucose was estimated by a "glucose oxidase-peroxidase" method. Diabetes was diagnosed according to "American Diabetes Association" when a previous or current 12 h fasting glucose level is 7 mmol/L or greater (≥ 126 mg %).
Lipid profile
Serum total cholesterol was measured by "cholesterol oxidase-peroxidase" method. Patients who used cholesterol lowering medication or had a total serum cholesterol level ≥ 200 mg/dL [15] or triglycerides > 200 mg/dL [16] or HDL-C < 40 [17] were classified as having Dyslipidemia.
Anthropometric measurements

Body mass index measurement
Body mass index (BMI) was calculated by using the formula: BMI = weight (in kilograms)/height (in meters) 2 . All CRF patients and healthy controls were non-obese (Obesity was defined as a body mass index (BMI) of ≥ 25 kg/m 2 ) [17] .
Blood pressure estimation
Hypertension was diagnosed when a patient had systolic blood pressure (BP) ≥ 140 mmHg and/or diastolic BP ≥ 90 mmHg after taking 5 minutes rest or had received medicine for hypertension [18] . The average of three BP measurements was used for final estimation of BP.
CAIMT measurement
CAIMT was performed with a 7 MHz B-mode ultrasound system (Philips-HD7 Diagnostic Ultrasound System, made in China). The IMT was defined as the distance between the leading edge of the luminal echo to the leading edge of the adventitia of the media, was measured at the diastolic phase (Fig. 1) . The B-mode scanning protocol included the scanning of the right and left common carotid arteries (3 cm before the carotid bifurcation), carotid bifurcation, as well as of the internal carotid artery 2 cm distally from the carotid bifurcation [19] . Measurements were always performed in plaque-free arterial segments [20] .
Others
Hemodialysis
Hemodialyzed patients were identified as who had been on regular hemodialysis treatment (treated thrice weekly) for at least 6 months [21] .
Smoking
Participants were classified as non-smokers if they responded that they had smoked fewer than 100 cigarettes or 5 packs of cigarettes during their lifetime [22] . All examinations and measurements were performed by same examiner to exclude examiner bias. ear multivariate regression analysis with 95 percent confidence interval were performed for data analysis. P value less than 0.05 was taken as statistically significant. Data were expressed as means ± SE (standard Error). All these analysis were performed using a commercially available software SPSS (17th version for window) on personal computer.
Statistical methods
Chi-square test, Paired t test, independent samples t test, lin-
Results
Here CRF patients and healthy controls were age (P value = 0.605) and sex (P value = 0.467) matched. CRF patients with hyperuricemia and without hyperuricemia were also age (P value = 0.380) and sex (P value = 0.074) matched.
There was no difference of GFR between CRF patients with hyperuricemia and without hyperuricemia (P value = 0.603).
In this study, 45.71% hyperuricemic CRF patients had diabetes and mean fasting blood sugar in this group 134.88 ± 7.42 mg/dl. 85.71% and 57.14 % CRF patients with hyperuricemia were associated with hypertension and dyslipidemia respectively.
In our study, CRF patients with hyperuricemia had significantly higher CAIMT (1051.22 ± 15.60 micron, P value = 0.000) compared to CAIMT of CRF patients without hyperuricemia (857.56 ± 15.95 micron) ( Table 3) .
It was also shown that hyperuricemic CRF patients had higher CAIMT (1051.22 ± 15.60 micron, P value = 0.000) than age (P value = 0.786) and sex (P value = 0.058) matched healthy controls (707.16 ± 6.79 micron) ( Table 3) .
In CRF patients, multivariate regression analysis showed CAIMT was positively correlated with age (P = 0.044), sex (P = 0.07), smoking (P = 0.004), dyslipidemia (P = 0.001), hypertension (P = 0.002), dialysis (P = 0.004), 24 hours total urine albumin excretion (P = 0.002), fasting blood sugar (P = 0.000) and hyperuricemia (P = 0.018), and negatively correlated with GRF (P = 0.000). So, hyperuricemia was independently correlated with CAIMT in CRF patients (Table 4) .
Our study documented that hyperuricemic CRF patients had higher albuminuria (1148.71 ± 81.19 g/24 hours, P value = 0.000) compared to CRF patients without hyperuricemia (652.99 ± 47.73 mg/24 hours).
In hyperuricemic CRF patients, prevalence of hypertension was significantly higher (85.71% P value = 0.000) than non-hyperuricemic CRF patients (51.54%).
Hyperuricemic CRF patients had significantly higher fasting blood sugar (134.88 ± 7.42 mg/dL, P value = 0.000) than CRF patients without hyperuricemia (102.40 ± 2.89 mg/dL). There were also higher prevalence of fasting blood sugar in CRF patients with hyperuricemia than CRF patients without hyperuricemia (P value = 0.007).
Discussion
Kawamato et al [23] and Neogi T et al [24] found that SUA is an independent risk factor of atherosclerosis along with known risk factors such as age, sex, smoking, hypertension, dyslipidemia, etc. Our study also showed same finding. In our study, there was also significantly higher CAIMT in hyperuricemic CRF patients than non-hyperuricemic CRF patients and healthy controls. So, aggressive treatment of hyperuricemia may halt or slow the progression of atherosclerosis in CRF patients.
In concordance with "Normative aging study" [25] , Elsayed et al [26] , Tavil Y et al [2] our study also demonstrated that the hyperuricemia predicts the development of hypertension. So, controls of hyperuricemia can control hypertension in CRF patients and halt or slow the further progression of atherosclerosis.
Tseng et al [27] and Fukui et al [28] documented that hyperuricemia was associated with increased urinary albumin excretion. But Obermayr RP et al [10] reported that there was lack of relationship between SUA and proteinuria. Our study showed that albuminuria was significantly higher in hyperuricemic CRF patients than non-hyperuricemic CRF patients. So, controls of hyperuricemia can halt or slow the further progression of atherosclerosis by reducing albuminuria in CRF patients.
Viazzi F et al [29] , Dehghan A et al [30] and Wiik BP et al [31] reported that hyperuricemia predict development of new onset diabetes. Our study also showed that Hyperuricemic CRF patients had significantly higher incidence of diabetes than CRF patients without hyperuricemia. So, controls of hyperuricemia can halt or slow the further progression of atherosclerosis by reducing development of new onset diabetes in CRF patients. There were some limitations in this study because [1] premature atherosclerosis, serum homocysteine, lipoprotein (a), physical activity, atherogenic diet, pro-inflammatory factors and pro-thrombotic factors could not be examined due to the limitations of budget and study design, [2] small numbers of participants were included.
Conclusions
Hyperuricemia is independently responsible for increased thickening of carotid artery intima media thickness and also associated with higher level of albuminuria, and higher prevalence of hypertension and diabetes in CRF patients. So, aggressive control of hyperuricemia may halt or slow the progression of carotid artery intima media thickening in CRF patients. There is no difference of GFR between CRF patients with hyperuricemia and without hyperuricemia. 
